This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
etfs: Archive
Biotech ETF (XBI) Hits New 52-Week High
by Zacks Equity Research
XBI hits a fresh 52-week high after a sharp rebound in biotech momentum fueled by favorable regulation, valuations and improving funding trends.
etfs
IEA Predicts 20M Electric Car Sales in 2025: ETFs Poised to Gain
by Aparajita Dutta
DRIV and KARS stand out as EV-focused ETFs are poised to benefit from the IEA's forecast of more than 20M electric car sales in 2025.
autonomous-vehicles batteries electric-vehicles etfs
Is Alphabet Berkshire's New "Mag-7" Favorite? ETFs in Focus
by Sanghamitra Saha
Berkshire's surprise Alphabet buy sparks buzz. Is GOOGL the new Mag-7 favorite? ETFs like GXPC, FCOM, IXP and VOX stand to gain from the momentum.
etfs tech-stocks
Best-Performing ETFs of Last Week
by Sanghamitra Saha
Top ETFs that soared last week despite market swings included shipping (BWET), lithium miners (LITP), crypto bear (REKT), biotech (BBC) and rare earths (REMX).
etfs
Market Turbulence Ahead? Volatility ETFs to Consider
by Yashwardhan Jain
As tech selling raises volatility and rate-cut hopes fade, volatility ETFs stand out as a timely way to navigate near-term market swings.
etfs
Tesla's Shares Tumble: A Tactical Entry Point for ETF Investors?
by Aparajita Dutta
TSLA's sharp drop puts ETFs like XLY and DRIV in focus as investors weigh risks, valuation pressure and long-term innovation bets.
electric-vehicles etfs
Buffett's Investing Lessons: What They Mean for ETF Investors
by Sanghamitra Saha
Buffett's final lessons guide ETF investors toward discipline, cash strength and quality picks like SPY, ITOT, VTV and MINT.
etfs
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
by Aparajita Dutta
Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.
earnings etfs medical
Zacks Investment Ideas feature highlights: IWM, CoreWeave, Astera Labs, Nebius, Expand Energy, Eli Lilly and Nvidia
by Zacks Equity Research
Zacks Investment Ideas tracks market shifts as IWM strength, AI stock rotation and Nvidia's key support test shape year-end positioning.
alt-energy computers etfs pharmaceuticals semiconductor tech-stocks
6 Dividend ETFs Under $50 to Buy Now
by Sanghamitra Saha
Market volatility sparks income hunt -- dividend ETFs like SCHD, CGDV, SPYD, IDV, FDL & DIVO under $50 offer steady yields and value.
etfs